Intraoperative Sublingual Sufentanil for Acute Pain in the Ambulatory Surgery Center
Latest Information Update: 02 Feb 2024
At a glance
- Drugs Sufentanil (Primary)
- Indications Perioperative pain
- Focus Therapeutic Use
Most Recent Events
- 09 Jan 2024 According to Talphera media release, AcelRx Pharmaceuticals changed its name to Talphera, Inc.
- 21 Apr 2021 Status changed from recruiting to completed.
- 09 Nov 2020 Planned End Date changed from 1 Sep 2020 to 1 Feb 2021.